Svea Wupper

Svea is a DPhil student at the University of Oxford researching innate immunity and cancer immunotherapy, focusing on the cGAS–STING pathway and intercellular cGAMP signalling. Her research combines innovative 3D organoid models and in vitro systems to explore new therapeutic opportunities. Passionate about translating scientific discoveries into clinical applications, she is actively involved in the biotechnology sector through the Oxford University Biotech Society, where she has contributed to strategic consulting projects in cancer immunotherapy and currently serves as senior VP of consulting. Svea is particularly interested in bridging academic research and biotechnology innovation.